1-1 of 1
Dagmar Kubitza, MD, PhD
Close
Sort by
Journal Articles

Naproxen Has No Relevant Effect on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor.

Dagmar Kubitza, MD, PhD, Michael Becka, MD, Wolfgang Mueck, MD, Michael Zuehlsdorf, MD
Journal: Blood
Blood (2005) 106 (11): 1873.
https://doi.org/10.1182/blood.V106.11.1873.1873
Published: 2005